These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 1618961)
1. Determination of yohimbine and its two hydroxylated metabolites in humans by high-performance liquid chromatography and mass spectral analysis. Le Verge R; Le Corre P; Chevanne F; Döe De Maindreville M; Royer D; Levy J J Chromatogr; 1992 Feb; 574(2):283-92. PubMed ID: 1618961 [TBL] [Abstract][Full Text] [Related]
2. Biopharmaceutics and metabolism of yohimbine in humans. Le Corre P; Dollo G; Chevanne F; Le Verge R Eur J Pharm Sci; 1999 Oct; 9(1):79-84. PubMed ID: 10494000 [TBL] [Abstract][Full Text] [Related]
3. [Determination of yohimbine in serum by high performance liquid chromatography]. Chiba R; Isii Y Yakugaku Zasshi; 1990 Apr; 110(4):289-92. PubMed ID: 2376823 [TBL] [Abstract][Full Text] [Related]
4. Hydroxylation of yohimbine in superacidic media: one-step access to human metabolites 10 and 11-hydroxyyohimbine. Duflos A; Redoules F; Fahy J; Jacquesy JC; Jouannetaud MP J Nat Prod; 2001 Feb; 64(2):193-5. PubMed ID: 11429998 [TBL] [Abstract][Full Text] [Related]
5. Determination of genkwanin in rat plasma by liquid chromatography-tandem mass spectrometry: application to a bioavailability study. Song Y; Zhang S; Liu H; Jin X J Pharm Biomed Anal; 2013 Oct; 84():129-34. PubMed ID: 23831487 [TBL] [Abstract][Full Text] [Related]
6. Determination of losartan, telmisartan, and valsartan by direct injection of human urine into a column-switching liquid chromatographic system with fluorescence detection. del Rosario Brunetto M; Contreras Y; Clavijo S; Torres D; Delgado Y; Ovalles F; Ayala C; Gallignani M; Estela JM; Martin VC J Pharm Biomed Anal; 2009 Sep; 50(2):194-9. PubMed ID: 19446420 [TBL] [Abstract][Full Text] [Related]
7. Optimizing high-performance liquid chromatography method with fluorescence detection for quantification of tamoxifen and two metabolites in human plasma: application to a clinical study. Zhu YB; Zhang Q; Zou JJ; Yu CX; Xiao DW J Pharm Biomed Anal; 2008 Jan; 46(2):349-55. PubMed ID: 18037598 [TBL] [Abstract][Full Text] [Related]
8. A liquid chromatographic procedure for the analysis of yohimbine in equine serum and urine. Reimer G; Suarez A; Chui YC J Anal Toxicol; 1993; 17(3):178-81. PubMed ID: 8336492 [TBL] [Abstract][Full Text] [Related]
9. Rapid resolution liquid chromatography-mass spectrometry and high-performance liquid chromatography-fluorescence detection for metabolism and pharmacokinetic studies of ergosta-4,6,8(14),22-tetraen-3-one. Zhao YY; Qin XY; Cheng XL; Liu XY; Lin RC; Zhang Y; Li XY; Sun XL; Sun WJ Anal Chim Acta; 2010 Aug; 675(2):199-206. PubMed ID: 20800733 [TBL] [Abstract][Full Text] [Related]
10. Sensitive determination of trimetazidine in spiked human plasma by HPLC with fluorescence detection after pre-column derivatization with 9-fluorenylmethyl chloroformate. Khedr A; Sheha MM; Darwish IA J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):337-42. PubMed ID: 17644495 [TBL] [Abstract][Full Text] [Related]
11. High-performance liquid chromatographic assay for imipramine, desipramine, and their 2-hydroxylated metabolites. Sutfin TA; Jusko WJ J Pharm Sci; 1979 Jun; 68(6):703-5. PubMed ID: 458567 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous determination of mexiletine and four hydroxylated metabolites in human serum by high-performance liquid chromatography and its application to pharmacokinetic studies. Paczkowski D; Filipek M; Mielniczuk Z; Andrzejczak J; Popławska W; Sitkiewicz D J Chromatogr; 1992 Jan; 573(2):235-46. PubMed ID: 1601956 [TBL] [Abstract][Full Text] [Related]
13. Three-phase, liquid-phase microextraction combined with high performance liquid chromatography-fluorescence detection for the simultaneous determination of fluoxetine and norfluoxetine in human plasma. de Freitas DF; Porto CE; Vieira EP; de Siqueira ME J Pharm Biomed Anal; 2010 Jan; 51(1):170-7. PubMed ID: 19683889 [TBL] [Abstract][Full Text] [Related]
14. Sensitive and selective liquid chromatography-mass spectrometry method for the quantification of rosiglitazone in human plasma. He J; Hu YF; Duan LF; Tan ZR; Wang LS; Wang D; Zhang W; Li Z; Liu J; Tu JH; Yao YM; Zhou HH J Pharm Biomed Anal; 2007 Jan; 43(2):580-5. PubMed ID: 16934427 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of a novel KDR kinase inhibitor and its N-oxide metabolite in human plasma using 96-well solid-phase extraction and liquid chromatography/tandem mass spectrometry. Xu Y; Du L; Soli ED; Braun MP; Dean DC; Musson DG J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Mar; 817(2):287-96. PubMed ID: 15686997 [TBL] [Abstract][Full Text] [Related]
16. High-performance liquid chromatography method for determining alendronate sodium in human plasma by detecting fluorescence: application to a pharmacokinetic study in humans. Yun MH; Kwon KI J Pharm Biomed Anal; 2006 Jan; 40(1):168-72. PubMed ID: 16095861 [TBL] [Abstract][Full Text] [Related]
17. Determination and validation of duloxetine hydrochloride in capsules by HPLC with pre-column derivatization and fluorescence detection. Tatar Ulu S J Chromatogr Sci; 2012 Jul; 50(6):494-8. PubMed ID: 22511287 [TBL] [Abstract][Full Text] [Related]
18. Determination of NVP-BEZ235, a dual PI3K and mTOR inhibitor, in human and mouse plasma and in mouse tissue homogenates by reversed-phase high-performance liquid chromatography with fluorescence detection. Lin F; Chandrasekaran G; de Gooijer MC; Beijnen JH; van Tellingen O J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 901():9-17. PubMed ID: 22727754 [TBL] [Abstract][Full Text] [Related]
19. Determination of tianeptine in human plasma using high-performance liquid chromatography with fluorescence detection. Tatar Ulu S J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Apr; 834(1-2):62-7. PubMed ID: 16520099 [TBL] [Abstract][Full Text] [Related]
20. Optimization of ultra-performance liquid chromatography (UPLC) with fluorescence detector (FLD) method for the quantitative determination of selected neurotransmitters in rat brain. Stragierowicz J; Daragó A; Brzeźnicki S; Kilanowicz A Med Pr; 2017 Jul; 68(5):583-591. PubMed ID: 28749489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]